Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 354.26M P/E - EPS this Y 15.60% Ern Qtrly Grth -
Income -62.26M Forward P/E -9.21 EPS next Y 42.10% 50D Avg Chg -3.00%
Sales 163.91M PEG - EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 11.78 EPS next 5Y - 52W High Chg -16.00%
Recommedations 1.50 Quick Ratio 1.17 Shares Outstanding 148.25M 52W Low Chg 166.00%
Insider Own 3.74% ROA -8.25% Shares Float 134.19M Beta 1.11
Inst Own 42.17% ROE -324.20% Shares Shorted/Prior 8.94M/9.24M Price 2.58
Gross Margin 82.52% Profit Margin -37.98% Avg. Volume 1,188,125 Target Price 4.75
Oper. Margin -22.17% Earnings Date Mar 6 Volume 669,522 Change -4.09%
About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Xeris Biopharma Holdings, Inc. News
04/17/24 Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
04/05/24 Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
04/03/24 Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/02/24 Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/09/24 Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
03/07/24 Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
03/07/24 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
03/06/24 Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
03/06/24 Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
03/06/24 Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
03/06/24 Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
03/05/24 Why Xeris (XERS) Might Surprise This Earnings Season
02/28/24 Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
02/05/24 Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
01/11/24 Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
01/10/24 Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab
01/08/24 7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
01/04/24 Xeris Biopharma Updates Its Outlook for 2023
12/27/23 Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/23/23 11 High Growth Micro-Cap Stocks to Buy
XERS Chatroom

User Image astroflyery1 Posted - 41 minutes ago

$OPTN $MREO $HRTX $XERS $XBI I'm very excited to announce that I have acquired 50.000 Shares of OptiNose Inc. Let's hope for the best :)

User Image StarF Posted - 58 minutes ago

$XERS wow what a surprise

User Image Brodman Posted - 1 hour ago

$XERS Looking like this will be the 8th consecutive weekly RED close....nothing stopping this from going to $1....1qtr earnings will be the just another nail in the coffin for this company. Will not see $2 the rest of this year!!!!

User Image HorizonBull Posted - 11 hours ago

$XERS keep loading. should be 5+

User Image Vakeshka Posted - 13 hours ago

$XERS at least in the short term, turned out a good move. Sold 11k shares for 40% profit and moved proceeds into IBIT (+15% to date). Still see solid potential in this company, just expect higher upside in bitcoin over the next 4-5 years. Glta.

User Image Green_Johnnie Posted - 13 hours ago

$XERS wtf is wrong with this company… learned so much though. thanks to xers.

User Image Alon_R Posted - 14 hours ago

$XERS If one see the broad picture, he can understand, that beside of sales growth YoY, Which factually increase our revenue and minimize our lost, to a distance we are not far of profitability (another year like last 3 years would be sufficient). As well as we are just in 'Xeriject fruition distance', to be be very strong financially. And we have Levothyroxine phase II finalization, most likely soon, as potentially the only company, that would suggest in the foreseeable future once-weekly drug solution, rather than everyday... Blockbuster potential right here. I, personally, respect Paul Edick doings and fully understand his methodical strategy(and hopeful he would maintain it of course)... As we only need more of the same(and maybe soon even much more than only "more of the same" via Xeriject deals and afterwards Levothyroxine) and by doing so, he will stand behind his commitment to investors, beside of suggesting better and easier method of medical solution for those in need.

User Image mountainmain Posted - 17 hours ago

$XERS What a shitty management when longs have to scrape through internet to find something positive to post about the company.

User Image Xanderzzzzzzz Posted - 18 hours ago

$XERS

User Image cheetohottaki Posted - 18 hours ago

$XERS 25% or so down on year, exciting times.....smh

User Image acinvestor13 Posted - 18 hours ago

$XERS Something also going on with Gvoke and glucagon market. NOT GOOD! Should SELL ASAP

User Image acinvestor13 Posted - 19 hours ago

$XERS VOTE NO on june 5! Force a sale! Why pay for these chumps salaries and bonuses and fancy offices? Company could likely fetch 2.50-3, and no one would have to suffer here anymore.

User Image Brodman Posted - 20 hours ago

$XERS March 2020 $1.95, 4 years later $1.77....no one is buying this garbage. No way they survive, hope for a buyout and can get $2.50...not a lot worth buying?????

User Image Brodman Posted - 22 hours ago

$XERS Amazing how quickly XERS has fallen apart....revenue slowing dramatically, spending increasing, debt rising, no revenue producing partnerships, nothing in the pipeline and a Mgmt team that only knows how to spend vs create value. That all says it's a company failing and it doesn't have much of a future. Shareholders are f------d!

User Image APIS_BULL Posted - 22 hours ago

$XERS I don't think I could name a stock that performed so poorly the past 4 years.. I you can find me something that performed worst than this one please hit me up... I have no one to blame but myself but man..

User Image mountainmain Posted - 1 day ago

$XERS Voting against

User Image goodluck2all Posted - 1 day ago

$XERS thank goodness longs learned not to dance when 5% is up😀

User Image Savvy7 Posted - 1 day ago

$XERS Oh, how I've come to just hate looking at this stock every day. Hopeless.

User Image Sparky202 Posted - 1 day ago

$XERS My apologies I think I was in a rush and botched my reading of what it meant to remove the evergreen. I'll read it more later but they still may have that 85% of FMV provision. https://www.sec.gov/ix?doc=/Archives/edgar/data/1867096/000186709624000053/xers-20240423.htm

User Image Brodman Posted - 1 day ago

$XERS Still looking like an 8th consecutive week ending in RED. To say there are no positives is an understatement. XERS won't see $3 this year for sure, it might linger below $2 for the rest of the year.

User Image ronday19200 Posted - 1 day ago

$XERS go!!

User Image c_sonnier Posted - 1 day ago

$XERS Over $2 we go! 🚀🚀🚀💎🙌

User Image Xanderzzzzzzz Posted - 1 day ago

$XERS Importantly, single SC doses of XP-8121 at all doses were well-tolerated and the XP-8121 doses studied were generally comparable to Synthroid 600 μg PO with respect to the safety findings. In June 2023, we initiated a non-randomized, open-label, single arm, self-controlled Phase 2 study to determine a target dose conversion factor from stably dosed oral levothyroxine to XP-8121 in patients with hypothyroidism and also assess the safety and tolerability after onceweekly subcutaneous injections. In November 2023, the study was over 85% enrolled and should be completed in the first half of 2024.

User Image Xanderzzzzzzz Posted - 1 day ago

$XERS XP-8121 is designed to be a once-weekly, small-volume, subcutaneous injection which, given its route of administration, bypasses the gastrointestinal tract and could avoid many of the therapeutic complications associated with the use of oral forms of levothyroxine. We believe that our novel approach to treatment has the potential to establish a new standard of care for hypothyroidism. Given the size of the impacted patient population and the challenges faced by certain patients, we estimate the potential market opportunity for XP-8121 to be $2.0 to $3.0 billion dollars annually

User Image acinvestor13 Posted - 1 day ago

$XERS VOTE PAUL OUT JUNE 5th! Force a sale

User Image LionFox Posted - 1 day ago

$XERS they are on a hiring spree. https://stonks-helper.com/public/dashboard/631e0bef-c507-4370-86a3-b9f4295a7dab

User Image astroflyery1 Posted - 1 day ago

$HRTX $MREO $XERS $STRO $SPY Old investment almanacs posit that if the first five trading days of the S&P500's new year are net positive or negative, it predicts a gain or loss for the full 12 months. Hocus pocus or not, the 'five-day rule' has proven correct for five years running - despite unforeseen curve balls

User Image dave2ta Posted - 1 day ago

$XERS My new album is now available on all the Digital Streaming and Download Platforms. Here is a link to the Spotify site .. I hope you enjoy the music, and share it with everyone you know... Every Stream and Download helps... https://open.spotify.com/album/2QOuw62TQkAa8ElNDeFkTa?si=MBwb5PkjR-SnS8IC2sJr9w

User Image darntootin Posted - 1 day ago

$XERS https://ir.xerispharma.com/node/10706/html

User Image darntootin Posted - 1 day ago

$XERS https://ir.xerispharma.com/static-files/55192569-bed6-4847-858e-da9df92b46a2

Analyst Ratings
Oppenheimer Outperform Mar 28, 24
HC Wainwright & Co. Buy Mar 7, 24
HC Wainwright & Co. Buy Nov 13, 23
Piper Sandler Overweight Nov 10, 23
Craig-Hallum Buy Aug 28, 23
HC Wainwright & Co. Buy Aug 9, 23
HC Wainwright & Co. Buy May 10, 23
HC Wainwright & Co. Buy Mar 9, 23
SVB Leerink Outperform Jan 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schmid John P. Director Director Nov 16 Buy 1.51 6,500 9,815 6,500 11/17/23
Shannon John Patrick Jr See Remarks See Remarks Nov 17 Buy 1.638 30,769 50,400 1,408,575 11/17/23
Edick Paul R See Remarks See Remarks Aug 09 Buy 2.3794 10,000 23,794 2,288,064 08/09/23